Results 1 - 10 of 18

Hara M; Abe T; Sugawara S; Mizushima Y; Hoshi K; Irimajiri S; Hashimoto H; Yoshino S; Matsui N; Nobunaga M; Nakano S. Efficacy and safety of iguratimod compared with placebo and salazosulfapyridine in active rheumatoid arthritis: a controlled, multicenter, double-blind, parallel-group study., Modern rheumatology
[DOI: 10.1007/s10165-006-0542-y]
DLI Caused by Disease-Modifying Antirheumatic Drugs: What Are the Characteristics of DLI by Disease-Modifying Antirheumatic Drugs?, Drug-Induced Lung Injury
[DOI: 10.1007/978-981-10-4466-3_12]
Effect of iguratimod and other anti-rheumatic drugs on adenocarcinoma colon 26-induced cachexia in mice, Inflammation Research
[DOI: 10.1007/s00011-007-6022-9]
Anti-allodynic action of the disease-modifying anti-rheumatic drug iguratimod in a rat model of neuropathic pain, Inflammation Research
[DOI: 10.1007/s00011-017-1064-0]
Iguratimod in combination with methotrexate in active rheumatoidn arthritis, Zeitschrift f??r Rheumatologie
[DOI: 10.1007/s00393-015-1641-y]
A randomized phase I study to evaluate the safety, tolerability, pharmacokinetics and food-effect of Iguratimod in healthy adult volunteers, European Journal of Clinical Pharmacology
[DOI: 10.1007/s00228-017-2342-z]
Effects of iguratimod on the levels of circulating regulators of bone remodeling and bone remodeling markers in patients with rheumatoid arthritis, Clinical Rheumatology
[DOI: 10.1007/s10067-017-3668-8]
Long-term safety study of iguratimod in patients with rheumatoid arthritis, Modern Rheumatology
[DOI: 10.1007/s10165-006-0543-x]
Concomitant iguratimod therapy in patients with active rheumatoid arthritis despite stable doses of methotrexate: a randomized, double-blind, placebo-controlled trial, Modern Rheumatology
[DOI: 10.1007/s10165-012-0724-8]
Efficacy and safety evaluation of a combination of iguratimod and methotrexate therapy for active rheumatoid arthritis patients: a randomized controlled trial, Clinical Rheumatology
[DOI: 10.1007/s10067-015-2999-6]